Contrasting HeartSciences (NASDAQ:HSCS) & Rennova Health (OTCMKTS:RNVA)

Rennova Health (OTCMKTS:RNVA) and HeartSciences (NASDAQ:HSCS) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, analyst recommendations, risk, valuation, dividends and institutional ownership.

Analyst Recommendations

This is a breakdown of recent recommendations for Rennova Health and HeartSciences, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rennova Health	0	0	0	0	0.00
HeartSciences	1	0	1	0	2.00

HeartSciences has a consensus target price of $8.00, indicating a potential upside of 282.78%. Given HeartSciences’ stronger consensus rating and higher probable upside, analysts clearly believe HeartSciences is more favorable than Rennova Health.

Insider & Institutional Ownership

17.2% of HeartSciences shares are owned by institutional investors. 20.2% of Rennova Health shares are owned by company insiders. Comparatively, 4.9% of HeartSciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Risk & Volatility

Rennova Health has a beta of 22.39, meaning that its share price is 2,139% more volatile than the S&P 500. Comparatively, HeartSciences has a beta of 2.44, meaning that its share price is 144% more volatile than the S&P 500.

Profitability

This table compares Rennova Health and HeartSciences’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Rennova Health	N/A	N/A	N/A
HeartSciences	N/A	-333.50%	-140.18%

Earnings & Valuation

This table compares Rennova Health and HeartSciences”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rennova Health	$18.69 million	0.00	-$7.73 million	N/A	N/A
HeartSciences	N/A	N/A	-$8.77 million	($4.94)	-0.42

Rennova Health has higher revenue and earnings than HeartSciences.

Summary

Rennova Health beats HeartSciences on 6 of the 10 factors compared between the two stocks.

About Rennova Health

Rennova Health, Inc., together with its subsidiaries, provides health care services in the United States. It owns one operating hospital in Oneida, Tennessee; and a rural clinic in Williamsburg, Kentucky. The company is based in West Palm Beach, Florida.

About HeartSciences

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.